Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
NCT00285012
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
504
Enrollment
INDUSTRY
Sponsor class
Conditions
Smoking Cessation
Interventions
DRUG:
placebo
DRUG:
Varenicline Tartarate
Sponsor
Pfizer